Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Event, Trade Show

AgilVax to Present at the 2019 NYC Oncology Investor Conference

AgilVax Inc., announced today that Joseph Patti, PhD, President and Chief Executive Officer, will present an overview of the Company and provide an update on its portfolio of targeted antibody-based therapies addressing multiple cancers at the NYC Oncology Investor Conference on November 12, 2019 at 5:30 PM (ET). The conference is being held at the Perkins Coie law firm, 1155 6th Ave, New York City, NY.

AgilVax has demonstrated in preclinical in vivo models that antibodies to xCT were able to reduce primary tumor formation and the number of lung metastases. xCT overexpression occurs in several cancers leading to metabolic changes that reprograms cells for growth and progression. AgilVax has multiple solutions to target cancer cells that overexpress xCT and when used in combination with existing therapies or alone have the potential to create a durable response in patients suffering from colorectal and other metastatic cancers.

About AgilVax

AgilVax is a biopharmaceutical company developing targeted antibody-based products to treat multiple types of cancer. The Company has three development programs; an unmodified monoclonal antibody (mAb) targeting xCT, an antibody-drug conjugate targeting xCT, and AX09, a VLP-based xCT vaccine currently in cGMP production.

For more information, please visit http://www.agilvax.com.

These press releases may also interest you

at 02:28
Sivers IMA Holding AB today announces the launch of the new state-of-art 5G mmWave Dual Quad Beamformer IC's (BFIC) to be used in several 5G applications. These BFIC's are the result of a joint development project between Ampleon Netherlands B.V...

at 02:25
Foresight Autonomous Holdings Ltd. , an innovator in automotive vision systems, announced today an additional sale of a prototype of its QuadSight® four-camera vision system targeted for the semi-autonomous and autonomous vehicle market. The...

at 02:25
Mycronic AB (publ) has received an order for the new SLX mask writer from a customer in Asia. The customer already has mask writers from Mycronic. The order value for the chosen SLX configuration is between USD 3 and 4 million. Delivery is scheduled...

at 02:24
The coronavirus outbreak in China has led to the country's primary and secondary school students completing the unusual first lesson of the new school year online as internet + education has become the preferred choice of learning during these...

at 02:10
ZTE Corporation (0763.HK / 000063.SZ), a major international provider of telecommunications, enterprise and consumer technology solutions for the Mobile Internet, today released its SuperDSS solution, the industry's unique solution for tri-RAT...

at 02:05
PureTech Health plc (LSE: PRTC) ("PureTech" or the "Company") today announced that Daphne Zohar, founder and chief executive officer, will present at the 9th Annual SVB Leerink Global Healthcare Conference in New York on Tuesday, February 25, at 9:00...

News published on 7 november 2019 at 07:10 and distributed by: